TAKE THIS POLL |
|
|
- US health spending hits $2.2tn in 2007 6 Jan 2009 07:16 GMT
... loss hit drug companies. Sanofi sleeping pill Ambien, Coreg, a heart failure drug made GlaxoSmithKline and Pfizer Inc's blood pressure drug Norvasc all lost patent exclusivity in 2006, making room ...
- Info-Surge Signs New Account Manager for New England 6 Jan 2009 06:31 GMT
... with some of the most high profile clients in the industry, namely Pfizer Inc., GlaxoSmithKline, Forest Laboratories Inc., UCB Pharma, and Élan Pharmaceuticals. Ansted completed her Master of Public Health ...
- Pfizer Goes Shopping and Water Is Wet: News at 11! 6 Jan 2009 05:31 GMT
... a relatively large company like Gilead Sciences or a series of smaller acquisitions like GlaxoSmithKline announced last year with its purchases of Sirtris Pharmaceuticals and Genelabs Technologies, Pfizer needs to ...
- U.S. health spending hits $2.2 trillion in 2007 6 Jan 2009 05:20 GMT
... loss hit drug companies. ) sleeping pill Ambien, Coreg, a heart failure drug made GlaxoSmithKline ( ) blood pressure drug Norvasc all lost patent exclusivity in 2006, making room for ...
- Watson Pharmaceuticals receives FDA approval for mint coated nicotine gum 6 Jan 2009 03:31 GMT
... 4 mg strengths. Nicotine Polacrilex Gum, coated mint flavor, is the generic equivalent of GlaxoSmithKline Consumer Healthcare's Nicorette (R) fresh mint gum, which is used as an aid to smoking ...
- Pharma spending spree could swallow biotechs 6 Jan 2009 03:30 GMT
... global co-head of healthcare at Merrill Lynch. Several chief executives, including Andrew Witty at GlaxoSmithKline and Bernard Poussot at Wyeth, have already said they are suspending share buy-backs to take ...
- NSE: Bearish trend drags down share value by N120bn 6 Jan 2009 00:53 GMT
... NSE: Bearish trend drags down share value by N120bn NSE: ... Nigeria Plc N1.13, Zenith Bank Plc N0.87, Glaxo SmithKline Consumer Plc N0.69, Intercontinental Bank Plc N0.67, Costain ...
- --> Theravance Announces New Employment Inducement Award 6 Jan 2009 00:34 GMT
... Pharma Inc., the Horizon program and the Bifunctional Muscarinic Antagonist-Beta2 Agonist (MABA) program with GlaxoSmithKline plc, and the Gastrointestinal Motility Dysfunction program. By leveraging its proprietary insight of multivalency toward ...
- Theravance Announces New Employment Inducement Award 6 Jan 2009 00:20 GMT
... Pharma Inc., the Horizon program and the Bifunctional Muscarinic Antagonist-Beta2 Agonist (MABA) program with GlaxoSmithKline plc, and the Gastrointestinal Motility Dysfunction program. By leveraging its proprietary insight of multivalency toward ...
- California Pizza Kitchen Appoints Sue Collyns Chief Operating Officer and Executive Vice President 5 Jan 2009 21:20 GMT
... experience across several industries has included roles with such leading brands as Sony, Pepsi, GlaxoSmithKline and PriceWaterhouseCoopers. Her previous positions have included Vice President of Finance and Operations, Controller and ...
- The year was packed with health-related stories 5 Jan 2009 20:32 GMT
... legislative mental-health priorities. • Rochester lawyer Pual Dahlberg oversees a settlement with drug maker GlaxoSmithKline, repaying $40 million to insurance companies. Patients got a previous $63 million settlement. • Mayo ...
- Doctor Agrees to Cut Drug Firm Ties 5 Jan 2009 20:31 GMT
... said the WSJ, Nemeroff failed to report to Emory over $800,000 he received from GlaxoSmithKline for over 250 speaking engagements from January 2000 to January 2006. According to the Atlanta ...
- Galapagos Delivers Pre-clinical Candidate Drug in Alliance with GlaxoSmithKline and Receives '¬7.6 million in Milestone Payments 5 Jan 2009 19:31 GMT
... The pre-clinical candidate drug is a small molecule that meets all the chemical and biological criteria set ...
- Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in mileston 5 Jan 2009 19:13 GMT
... Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in milestone payments Galapagos NV (Euronext: GLPG) announced today that ...
- Galapagos Delivers Preclinical Candidate Drug in Alliance with GlaxoSmithKline and Receives EUR 7.6 Million in Milestone Payments 5 Jan 2009 19:12 GMT
... Galapagos Delivers Preclinical Candidate Drug in Alliance with GlaxoSmithKline and Receives EUR 7.6 Million in Milestone Payments MECHELEN, BELGIUM, January 5 / MARKET WIRE/ ...
- Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives ... 5 Jan 2009 18:50 GMT
... ...
- Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 5 Jan 2009 18:50 GMT
... Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in milestone payments Galapagos delivers pre-clinical candidate drug in alliance ...
- --> Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in milestone payments 5 Jan 2009 18:32 GMT
... Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in milestone payments MECHELEN, BELGIUM--(Marketwire - January 5, 2009) - ...
- Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives n7.6 million in milestone payments 5 Jan 2009 18:31 GMT
... Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives n7.6 million in milestone payments Jan 05, 2009 (Hugin via COMTEX News Network) ...
- Reader's portfolio 5 Jan 2009 18:30 GMT
... holdings are a nice mix of some higher-beta stocks (Apple and Investec) and defensives (GlaxoSmithKline, United Utilities and BAT), with more defensiveness added by the gilts and better quality corporate ...
- Research and Markets: South Africa Pharmaceuticals and Healthcare Report Q4 2008 - Between 2008 and 2012, it is Forecasted that the Average Drug Expenditure Growth will be 10.3% a Year 5 Jan 2009 18:30 GMT
... firm Aueros Capital for an undisclosed sum. -- Sanofi-Aventis -- Pfizer -- Roche -- GlaxoSmithKline -- Merck & Co -- Aspen Pharmacare -- Adcock Ingram -- Enaleni Pharmaceuticals ...
- Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in milestone payments 5 Jan 2009 18:20 GMT
... Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in milestone payments Last update: 1:09 p.m. EST Jan. 5, ...
- IIM-C fests insulated from downturn 5 Jan 2009 17:13 GMT
... IIM Calcutta’s experiential marketing expo ‘Census’, held in January ... Previous sponsors were Aditya Birla Group, ITC, Glaxo SmithKline, Cadbury, Hindustan Unilever Limited and RPG. IMRB ...
- Response Genetics amends its master service agreement with GlaxoSmithKline 5 Jan 2009 16:56 GMT
... proprietary and patented technologies, disclosed on 2 January that the master service agreement with GlaxoSmithKline Ltd (NYSE: GSK), a pharmaceutical and consumer health products company, has been amended and signed. ...
- Gartmore Global Tst - Portfolio Update 5 Jan 2009 16:32 GMT
... 3.6 Oracle 3,693 3.4 Nestle 3,551 3.3 Syngenta 3,271 3.0 National Grid 3,249 3.0 GlaxoSmithKline 3,208 3.0 Vodafone 3,100 2.9 JPMorgan Chase 3,090 2.9 Royal Dutch Shell 3,017 2.8 BG ...
1 - 25 of 202 next >
Powered by 
News by PR Newswire
24-7 pressrelease
|